|1|A phase 2 study of cediranib in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: A trial of the Princess Margaret, Chicago and California Phase II Consortia. (25895616)
Hirte H.... Oza A.M.
|2|Surgical diagnosis of stage I fallopian tube cancer in anti-Yo antibody paraneoplastic cerebellar degeneration. (24960213)
Haggerty A.F.... Tanyi J.
|3|A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer. (25494701)
Wang Y.... Kristensen G.
|4|Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared with fallopian tube cancer. (25514761)
Rauh-Hain J.A.... del Carmen M.G.
|5|Paraneoplastic Neurological Syndrome in Fallopian Tube Cancer. (25364036)
Maas E.... Jackisch C.
|6|MRP2 (ABCC2, cMOAT) expression in nuclear envelope of primary fallopian tube cancer cells is a new unfavorable prognostic factor. (23135210)
Halon A.... Surowiak P.
|7|Laparoscopic staging for apparent early stage ovarian or fallopian tube cancer. First case series from a UK cancer centre and systematic literature review. (23721765)
Brockbank E.C.... Barton D.P.
|8|Independent radiologic review of the Gynecologic Oncology Group Study 0218, a phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary peritoneal, or fallopian tube cancer. (23906656)
Burger R.A.... Bookman M.A.
|9|Early detection of ovarian and fallopian tube cancer by examination of cytological samples from the endometrial cavity. (23868002)
Otsuka I.... Hoshi K.
|10|Increased incidence of severe gastrointestinal events with first-line paclitaxel, carboplatin, and vorinostat chemotherapy for advanced-stage epithelial ovarian, primary peritoneal, and fallopian tube cancer. (23385285)
Mendivil A.A.... Goldstein B.H.
|11|OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer. (22529265)
Aghajanian C.... Nycum L.R.
|12|Outcome of single agent generic gemcitabine in platinum-resistant ovarian cancer, fallopian tube cancer and primary peritoneal adenocarcinoma. (22524817)
Suprasert P.... Manopunya M.
|13|Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer. (21992853)
Coleman R.L.... Sood A.K.
|14|Para-aortic lymphadenectomy for primary fallopian tube cancer. (20887989)
Koo Y.J.... Mok J.E.
|15|Junctional epithelial zones of the fallopian tube: cancer hotspots? (21131841)
Rabban J.T.... Zaloudek C.J.
|16|Asymptomatic primary fallopian tube cancer: an unusual cause of axillary lymphadenopathy. (22567506)
Healy N.A.... Sweeney K.J.
|17|Primary fallopian tube cancer in term pregnancy: a case report. (21614918)
Le A.... Wang Z.
|18|Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: results of a phase 2 study. (21815133)
McGonigle K.F.... Malpass T.W.
|19|Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. (19901115)
Makhija S.... Matulonis U.
|20|Immunohistochemical findings in primary fallopian tube cancer. Case report. (20349798)
Raba G.... Kanczuga-Koda L.
|21|Phase II evaluation of nanoparticle albumin-bound paclitaxel in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancer. (19224848)
Teneriello M.G.... Asmar L.
|22|High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy. (19574767)
Hirst J.E.... Field M.
|23|Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer. (19091388)
Kehoe S.M.... Chi D.S.
|24|Case report: Occurrence of fallopian tube cancer in a patient with previous history of estrogen receptor positive breast cancer. (20103847)
Chung C.... Yen Y.
|25|A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer. (18554700)
Konner J.... Aghajanian C.A.
|26|Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia. (18423560)
Nimeiri H.S.... .
|27|Fallopian tube cancer associated with paraneoplastic dermatomyositis -- asymptomatic multivisceral exacerbated dermatomyositis mimicking recurrent widespread malignant disease: case report. (18459555)
Seeber J.... Zeimet A.G.
|28|Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: a phase I and feasibility trial of the Gynecologic Oncology Group. (18597837)
Morgan M.A.... Egorin M.J.
|29|Fallopian tube cancer: radical surgery, extended field radiation and chemotherapy in 24 personal cases treated with "intent to cure". (18973932)
|30|Second primary malignancies in females with primary fallopian tube cancer. (17266029)
Riska A.... Brennan P.
|31|A phase II study of outpatient first-line paclitaxel, carboplatin, and bevacizumab for advanced-stage epithelial ovarian, peritoneal, and fallopian tube cancer. (17343605)
Micha J.P.... Brown J.V.
|32|Fallopian tube cancer: stepchild or mother? (18053873)
|33|The incidence of primary fallopian tube cancer in the United States. (17961642)
Stewart S.L.... Michaud F.
|34|A 10-year review of primary fallopian tube cancer at a community hospital: a high association of synchronous and metachronous cancers. (16445606)
Benoit M.F.... Hannigan E.V.
|35|The founder mutation BRCA1c.2845insA identified in a fallopian tube cancer patient: a case report. (16515624)
Damayanti Z.... Sng J.H.
|36|The significance of Doppler flow and anamnesis in the diagnosis of fallopian tube cancer. (15991534)
Gojnic M.... Jeremic K.
|37|A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer. (15581974)
Berkenblit A.... Cannistra S.A.
|38|Phase 2 trial of interferon-beta as second-line treatment of ovarian cancer, fallopian tube cancer, or primary carcinoma of the peritoneum. (15331919)
Markman M.... Lindner D.
|39|Phase 2 trial of single agent docetaxel in platinum and paclitaxel-refractory ovarian cancer, fallopian tube cancer, and primary carcinoma of the peritoneum. (14675679)
Markman M.... Belinson J.
|40|Preoperative diagnosis of fallopian tube cancer by imaging. (14628888)
Mikami M.... Fukuiya T.
|41|Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer. (12354934)
Jongsma A.P.... Kenemans P.
|42|Long-term survival of a patient with fallopian tube cancer presenting with a supraclavicular mass. (11205221)
Scholz H.S.... Petru E.
|43|Fallopian tube cancer as a feature of BRCA1-associated syndromes. (10926816)
Sobol H.... Eisinger F.
|44|Practice guidelines: fallopian tube cancer. Society of Gynecologic Oncologists Clinical Practice Guidelines. (9507528) |1998|
|45|Fallopian tube cancer: incidence and role of lymphatic spread. (8751549)
di Re E.... Baiocchi G.
|46|DNA-ploidy and mutant p53 overexpression in primary fallopian tube cancer. (11578443)
HellstrAPm A.C.... Auer G.
|47|Fallopian tube cancer metastatic to the breast. (8005136)
Fishman A.... Kaplan A.L.
|48|Staging rules for gestational trophoblastic tumors and fallopian tube cancer. (1317647)
|49|Fallopian tube cancer. The Roswell Park experience. (2249208)
Rose P.G.... Tsukada Y.
|50|Immunolymphoscintigraphy and immunoscintigraphy of ovarian and fallopian tube cancer using F(ab')2 fragments of monoclonal antibody OC 125. (2297745)
Lehtovirta P.... SeppAolAo M.